Insider Selling: Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) Major Shareholder Sells 5,580 Shares of Stock

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) major shareholder J.H. Whitney Equity Partners V sold 5,580 shares of the business’s stock in a transaction on Tuesday, April 1st. The shares were sold at an average price of $5.63, for a total transaction of $31,415.40. Following the completion of the transaction, the insider now owns 1,451,598 shares of the company’s stock, valued at approximately $8,172,496.74. This represents a 0.38 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Large shareholders that own 10% or more of a company’s stock are required to disclose their transactions with the SEC.

J.H. Whitney Equity Partners V also recently made the following trade(s):

• On Monday, March 24th, J.H. Whitney Equity Partners V sold 268 shares of Aveanna Healthcare stock. The stock was sold at an average price of $5.63, for a total value of $1,508.84.
• On Tuesday, March 18th, J.H. Whitney Equity Partners V sold 61,564 shares of Aveanna Healthcare stock. The shares were sold at an average price of $5.51, for a total transaction of $339,217.64.

Aveanna Healthcare Stock Performance

Shares of Aveanna Healthcare stock traded down $0.30 on Thursday, reaching $5.32. The company had a trading volume of 366,272 shares, compared to its average volume of 246,560. The firm has a market cap of $1.04 billion, a PE ratio of -15.65 and a beta of 2.25. The firm’s 50 day moving average price is $4.77 and its two-hundred day moving average price is $4.96. Aveanna Healthcare Holdings Inc. has a 52-week low of $2.11 and a 52-week high of $6.19.

Analyst Upgrades and Downgrades

A number of brokerages recently weighed in on AVAH. Truist Financial decreased their price target on shares of Aveanna Healthcare from $6.00 to $5.25 and set a “hold” rating on the stock in a research note on Monday, January 6th. UBS Group boosted their price target on Aveanna Healthcare from $3.20 to $4.50 and gave the stock a “sell” rating in a research report on Friday, March 14th.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in AVAH. Intech Investment Management LLC purchased a new position in Aveanna Healthcare during the 3rd quarter valued at about $69,000. Charles Schwab Investment Management Inc. lifted its position in shares of Aveanna Healthcare by 3.9% during the third quarter. Charles Schwab Investment Management Inc. now owns 462,659 shares of the company’s stock worth $2,406,000 after purchasing an additional 17,522 shares in the last quarter. The Manufacturers Life Insurance Company purchased a new position in shares of Aveanna Healthcare in the third quarter valued at approximately $136,000. Centiva Capital LP acquired a new position in shares of Aveanna Healthcare in the third quarter valued at approximately $138,000. Finally, Jacobs Levy Equity Management Inc. grew its holdings in shares of Aveanna Healthcare by 297.6% in the third quarter. Jacobs Levy Equity Management Inc. now owns 355,340 shares of the company’s stock valued at $1,848,000 after purchasing an additional 265,969 shares in the last quarter. 87.96% of the stock is currently owned by institutional investors and hedge funds.

Aveanna Healthcare Company Profile

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.